Cargando…

Identification of the effector domain of biglycan that facilitates BMP-2 osteogenic function

We have reported that recombinant biglycan (BGN) core protein accelerates bone formation in vivo by enhancing bone morphogenetic protein (BMP)-2 function. The purpose of the present study was to identify the specific domain (“effector”) within the BGN core protein that facilitates BMP-2 osteogenic f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jongwattanapisan, Prapaporn, Terajima, Masahiko, Miguez, Patricia A., Querido, William, Nagaoka, Hideaki, Sumida, Noriko, Gurysh, Elizabeth Grace, Ainslie, Kristy M., Pleshko, Nancy, Perera, Lalith, Yamauchi, Mitsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935668/ https://www.ncbi.nlm.nih.gov/pubmed/29728612 http://dx.doi.org/10.1038/s41598-018-25279-x

Ejemplares similares

Alfacalcidol enhances collagen quality in ovariectomized rat bones
por: Nagaoka, Hideaki, et al.
Publicado: (2014)

Hesperidin Promotes Osteogenesis and Modulates Collagen Matrix Organization and Mineralization In Vitro and In Vivo
por: Miguez, Patricia A., et al.
Publicado: (2021)

Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma
por: Pena, Erik S., et al.
Publicado: (2021)

Temporal Changes in Collagen Cross-Links in Spontaneous Articular Cartilage Repair
por: Terajima, Masahiko, et al.
Publicado: (2012)

Lupus-like Disease in FcγRIIB(−/−) Mice Induces Osteopenia
por: Visitchanakun, Peerapat, et al.
Publicado: (2019)

Characterization of Genipin-Modified Dentin Collagen
por: Nagaoka, Hiroko, et al.
Publicado: (2014)

The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021)

Biglycan regulates bone development and regeneration
por: Shainer, Reut, et al.
Publicado: (2023)

Breast cancer dataset with biomarker Biglycan
por: Silva Neto, Pedro Clarindo da, et al.
Publicado: (2023)

Applications of Vibrational Spectroscopy for Analysis of Connective Tissues
por: Querido, William, et al.
Publicado: (2021)

Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors
por: Shi, Ce, et al.
Publicado: (2016)

Proteomic analysis on effectors involved in BMP-2-induced osteogenic differentiation of beagle bone marrow mesenchymal stem cells
por: Hu, Ji-Jie, et al.
Publicado: (2014)

Expression and the Prognostic Value of Biglycan in Gastric Cancer
por: Hu, Sizhe, et al.
Publicado: (2022)

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities
por: Berasi, Stephen P, et al.
Publicado: (2011)

Biglycan: A Multivalent Proteoglycan Providing Structure and Signals
por: Nastase, Madalina V., et al.
Publicado: (2012)

Biglycan expression and its function in human ligamentum flavum
por: Salimi, Hamidullah, et al.
Publicado: (2021)

The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
por: Bolton, Kristy, et al.
Publicado: (2012)

Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis
por: Barreto, Goncalo, et al.
Publicado: (2015)

Decorin knockdown is beneficial for aged tendons in the presence of biglycan expression
por: Beach, Zakary M., et al.
Publicado: (2022)

Prevalence and Risk Factors of Feline Immunodeficiency Virus and Feline Leukemia Virus Infection in Healthy Cats in Thailand
por: Sprißler, Fabienne, et al.
Publicado: (2022)

Biglycan enhances gastric cancer invasion by activating FAK signaling pathway
por: Hu, Lei, et al.
Publicado: (2014)

Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013)

Inhibitory Role of the Small Leucine-Rich Proteoglycan Biglycan in Bladder Cancer
por: Niedworok, Christian, et al.
Publicado: (2013)

Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers
por: Zhao, Shou-Feng, et al.
Publicado: (2020)

Serum Decorin, Biglycan, and Extracellular Matrix Component Expression in Preterm Birth
por: Mennella, Jenna M., et al.
Publicado: (2020)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type)
por: De Kinderen, Pauline, et al.
Publicado: (2023)

Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain
por: Sunderland, Ashley, et al.
Publicado: (2023)

Sox9 Potentiates BMP2-Induced Chondrogenic Differentiation and Inhibits BMP2-Induced Osteogenic Differentiation
por: Liao, Junyi, et al.
Publicado: (2014)

Efficient autocrine and paracrine signaling explain the osteogenic superiority of transgenic BMP-2 over rhBMP-2
por: Atasoy-Zeybek, Aysegul, et al.
Publicado: (2023)

Sustained Release of BMP-2 in Bioprinted Alginate for Osteogenicity in Mice and Rats
por: Poldervaart, Michelle T., et al.
Publicado: (2013)

Effect of BMP-2 Delivery Mode on Osteogenic Differentiation of Stem Cells
por: Jung, Taekhee, et al.
Publicado: (2017)

Integration of Nodal and BMP Signaling by Mutual Signaling Effector Antagonism
por: Soh, Gary Huiming, et al.
Publicado: (2020)

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012)

Uterine Dysfunction in Biglycan and Decorin Deficient Mice Leads to Dystocia during Parturition
por: Wu, Zhiping, et al.
Publicado: (2012)

Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants
por: Hsieh, Louise Tzung-Harn, et al.
Publicado: (2017)

Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells
por: Subbarayan, Karthikeyan, et al.
Publicado: (2022)

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer
por: Morimoto, Hirofumi, et al.
Publicado: (2021)

Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy
por: Cong, Li, et al.
Publicado: (2021)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_veraqme09rqn785alj3rp9jgfu